Study of STI-7349 for advanced solid cancers
Treatments studied
Part of Cancer clinical trials.
This early-phase study tests STI-7349 (a new cancer treatment) in people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see how well it can control cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can read and understand the study and you sign consent willingly
- You are age 18 to 80, and your expected survival is at least 12 weeks
- Your cancer is a solid tumor that has been confirmed by tissue or fluid testing
- Your performance status is good (ECOG 0 to 1), and scans show at least one measurable tumor spot
- Your blood counts and organ tests (kidney, liver, and clotting) meet lab thresholds
- If you had prior cancer treatment, side effects must have mostly settled to mild levels (usually grade 1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral drug called ISM5939 for people with advanced solid tumors that haven't responded to or can't use standard treatments. The goal is to see if the drug is safe and works against the cancer.
This study tests a new drug (BGB-26808) alone or with another drug (tislelizumab) for people with advanced solid tumors that haven't responded to standard treatments. The goal is to see if the combination can help shrink tumors or slow their growth.
This early study tests a new medicine (BPI-460372) in adults with advanced solid cancers that have come back or can’t be treated with standard options. It may help by targeting specific cancer changes in certain tumors, and doctors will also learn the safest dose.
This trial tests a new drug called LPM6690176 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and how it affects the body.
This study tests an experimental drug called STX-1, given alone or with another drug that helps the immune system fight cancer. It is for people with advanced solid tumors, especially certain types of lung cancer or melanoma, who have already tried standard treatments.
This trial tests a new drug called PTT-4256 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to find the best dose and see if it helps shrink or control the cancer.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.